LOWES COMPANIES INC
LOW · NYSE · CIK 0000060667
SIC 5211
Retail-Lumber & Other Building Materials Dealers
Category
Retail
Entity
operating
Incorp.
NC
Fiscal Y/E
0131
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$226.14
-3.06 (-1.34%)
Open
$228.00
High
$229.00
Low
$224.50
Prev Close
$229.20
Volume
1,561,814
52W High
$291.66
52W Low
$206.27
50-day MA
$241.74
Quote as of: 2026-05-11
Market Cap
$129.31B
P/E
19.50
P/B
321.82
PEG
2.40
EPS
11.84
BPS
-17.68
Dividend Yield
2.04%
Beta
0.90
ROE
-67.10%
ROA
12.29%
D/E Ratio
-6.46
Current Ratio
1.08
Gross Margin
33.48%
Operating Margin
11.77%
Net Margin
7.71%
Book Value/Share
$-17.68
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (4 methods)
$83.99B
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | — | 순이익 또는 자본이 0 이하 |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | — | N/A |
Justified P/E 순이익 × 산업 평균 P/E | $99.81B | +30% |
P/B 배수 자본 × 산업 평균 P/B | — | 자본이 0 이하 |
P/S 배수 매출 × 산업 평균 P/S | $172.57B | -25% |
DCF (Gordon) CF × (1+g) / (r − g) | $68.16B | +90% |
DDM (Gordon) D × (1+g) / (r − g) | $23.48B | +451% |
▶ Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 4 were applicable. Their median fair-value lands +54.0% below the current market cap → the stock trades above most formulas' estimates (overvalued). 3 methods flag overvalued, 1 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
√(22.5 × 순이익 × 자본)
Not applicable: 순이익 또는 자본이 0 이하
Graham Formula
순이익 × (8.5 + 2 × 성장률%)
Not applicable: -
Justified P/E
Overvalued +29.6%순이익 × 산업 평균 P/E
Current
$129.31B
Implied fair
$99.81B
Gap (current − fair)
+$29.50B(+29.6%)
NetIncome = $6.65B Industry P/E = 15× $6.65B × 15 = $99.81B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
자본 × 산업 평균 P/B
Not applicable: 자본이 0 이하
P/S 배수
Undervalued -25.1%매출 × 산업 평균 P/S
Current
$129.31B
Implied fair
$172.57B
Gap (current − fair)
$-43.26B(-25.1%)
Revenue = $86.29B Industry P/S = 2× $86.29B × 2 = $172.57B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +89.7%CF × (1+g) / (r − g)
Current
$129.31B
Implied fair
$68.16B
Gap (current − fair)
+$61.14B(+89.7%)
FCF = $7.65B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $7.65B × (1 + -2.0%) / (9.0% − -2.0%) = $68.16B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 -2.0% (실질 GDP 수준)
DDM (Gordon)
Overvalued +450.6%D × (1+g) / (r − g)
Current
$129.31B
Implied fair
$23.48B
Gap (current − fair)
+$105.82B(+450.6%)
Dividend D = $2.64B Discount r = 9.0% Growth g = -2.0% $2.64B × (1 + -2.0%) / (9.0% − -2.0%) = $23.48B
- 배당 입력: 실제 지급 배당
- 할인율 9.0%
- 배당 영구 성장률 -2.0%
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +0.4% | +17.1% | +33.9% | +50.6% | +67.3% |
| 2% | -17.2% | -0.6% | +16.0% | +32.6% | +49.1% |
| 3% | -34.4% | -18.0% | -1.5% | +14.9% | +31.3% |
| 4% | -51.2% | -35.0% | -18.7% | -2.5% | +13.8% |
| 5% | -67.8% | -51.7% | -35.6% | -19.5% | -3.4% |
DDM sensitivity: discount rate × dividend growth
Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +191.4% | +240.0% | +288.5% | +337.1% | +385.7% |
| 2% | +140.5% | +188.6% | +236.6% | +284.7% | +332.8% |
| 3% | +90.5% | +138.1% | +185.8% | +233.4% | +281.0% |
| 4% | +41.5% | +88.7% | +135.8% | +183.0% | +230.2% |
| 5% | -6.6% | +40.2% | +86.9% | +133.6% | +180.3% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-03-23
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 86,286 | 83,674 | 86,377 | 97,059 | 96,250 |
| Cost of Revenue | 57,401 | 55,797 | 57,533 | 64,802 | 64,194 |
| Gross Profit | 28,885 | 27,877 | 28,844 | 32,257 | 32,056 |
| Operating Income | 10,153 | 10,466 | 11,557 | 10,159 | 12,093 |
| Net Income | 6,654 | 6,957 | 7,726 | 6,437 | 8,442 |
| EPS (Basic) | 11.87 | 12.25 | 13.23 | 10.20 | 12.07 |
| EPS (Diluted) | 11.85 | 12.23 | 13.20 | 10.17 | 12.04 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 54,144 | 43,102 | 41,795 | 43,708 | 44,640 |
| Current Assets | 20,955 | 20,358 | 19,071 | 21,442 | 20,060 |
| Cash & Equivalents | 982 | 1,761 | 921 | 1,348 | 1,133 |
| Total Liabilities | 64,061 | 57,333 | 56,845 | 57,962 | 49,456 |
| Current Liabilities | 19,463 | 18,757 | 15,568 | 19,511 | 19,668 |
| Long-term Debt | 39,819 | 35,319 | 35,770 | 33,270 | 24,285 |
| Total Equity | -9,917 | -14,231 | -15,050 | -14,254 | -4,816 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 9,864 | 9,625 | 8,140 | 8,589 | 10,113 |
| Investing CF | -12,264 | -1,738 | -1,901 | -1,309 | -1,646 |
| Financing CF | 1,621 | -7,047 | -6,666 | -7,049 | -12,016 |
| CapEx | 2,213 | 1,927 | 1,964 | 1,829 | 1,853 |
| Dividends Paid | 2,636 | 2,566 | 2,531 | 2,370 | 1,984 |
📄 SEC Filings
Proxy Statement
DEF 14A
2026-04-16
Open →
Annual Report
FORM 10-K
2026-03-23
Open →
Current Report
8-K
2026-02-25
Open →
Quarterly Report
10-Q
2025-11-26
Open →
Current Report
FORM 8-K
2025-11-19
Open →
Current Report
8-K
2025-10-09
Open →
Current Report
8-K
2025-09-30
Open →
Current Report
8-K
2025-09-19
Open →
Quarterly Report
10-Q
2025-08-28
Open →
Current Report
8-K
2025-08-20
Open →
Current Report
8-K
2025-08-20
Open →
Current Report
FORM 8-K
2025-06-05
Open →
Quarterly Report
FORM 10-Q
2025-05-29
Open →
Current Report
8-K
2025-05-21
Open →
Proxy Statement
DEF 14A
2025-04-17
Open →
Other filings (85)
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-05-06
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
ARS
ARS
2026-04-16
Open →
DEFA14A
DEFA14A
2026-04-16
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-02
Open →
Insider Transaction
FORM 4
2026-04-01
Open →
Insider Transaction
FORM 4
2026-04-01
Open →
Insider Transaction
FORM 4
2026-04-01
Open →
Insider Transaction
FORM 4
2026-04-01
Open →
Insider Transaction
FORM 4
2026-04-01
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
Insider Transaction
FORM 4
2026-03-05
Open →
144
xsl144X01/primary_doc.xml
2026-03-04
Open →
Insider Transaction
FORM 4
2026-01-12
Open →
144
xsl144X01/primary_doc.xml
2026-01-09
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2026-01-07
Open →
Insider Transaction
FORM 4
2026-01-02
Open →
Insider Transaction
FORM 4
2026-01-02
Open →
Insider Transaction
FORM 4
2026-01-02
Open →
Insider Transaction
FORM 4
2026-01-02
Open →
Insider Transaction
FORM 4
2026-01-02
Open →
Insider Transaction
FORM 4
2026-01-02
Open →
Insider Transaction
FORM 4
2025-12-16
Open →
Insider Transaction
FORM 4
2025-12-10
Open →
Insider Transaction
FORM 4
2025-11-25
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-10-31
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
Insider Transaction
FORM 4
2025-10-02
Open →
424B2
424B2
2025-09-25
Open →
FWP
FWP
2025-09-23
Open →
424B5
424B5
2025-09-23
Open →
Insider Transaction
FORM 4
2025-09-16
Open →
Insider Transaction
FORM 4
2025-09-12
Open →
144
xsl144X01/primary_doc.xml
2025-09-11
Open →
Insider Transaction
FORM 4
2025-09-08
Open →
144
xsl144X01/primary_doc.xml
2025-09-05
Open →
Insider Transaction
FORM 4
2025-08-27
Open →
144
xsl144X01/primary_doc.xml
2025-08-26
Open →
Insider Transaction
FORM 4
2025-08-21
Open →
144
xsl144X01/primary_doc.xml
2025-08-20
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X01/primary_doc.xml
2025-07-30
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-07-02
Open →
Insider Transaction
FORM 4
2025-06-17
Open →
11-K
FORM 11-K
2025-06-17
Open →
Insider Transaction
FORM 4
2025-06-12
Open →
144
xsl144X01/primary_doc.xml
2025-06-10
Open →
Insider Transaction
FORM 4
2025-06-05
Open →
144
xsl144X01/primary_doc.xml
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
SD
FORM SD
2025-05-29
Open →
8-K/A
8-K/A
2025-05-21
Open →
ARS
ARS
2025-04-17
Open →
DEFA14A
DEFA14A
2025-04-17
Open →
Insider Transaction
FORM 4
2025-04-03
Open →
Insider Transaction
FORM 4
2025-04-03
Open →
Insider Transaction
FORM 4
2025-04-03
Open →
Insider Transaction
FORM 4
2025-04-03
Open →